Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
25 drugs in development
By Therapeutic Area
top 6
R&D Momentum
100/100
Pipeline Velocity
85/100
Trial Completion Rate
72/100
Pipeline Concentration
21/100
Pipeline Freshness
71/100
Strategic Signals
Activity
Last 14 days
Autism Family Empowerment Coaching and Training Program (AFECT): Evaluating a Parent Coaching and Family Navigation Program for New Autism Spectrum Disorder Diagnosis
Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma
Phase I Clinical Trial of Locoregionally (LR) Delivered Autologous B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Adults With Recurrent Glioblastoma Multiforme (GBM)
Abdominal Scar Improvement in Microsurgical Breast Reconstruction
VISIONS: Voices Illuminating Solutions for Outdoor Workers' Needs and Safety
Addressing Diabetes by Elevating Access to Nutrition: The ADELANTE Study
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)